S. G. Marti,A. Alcaraz,P. Valanzasca,O. U. Garay,M. McMullen,L. R. Ares,V. Idrovo,J. P. Ortiz,M. Tapias,J. Obregon,J. G. Ariza and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN COLOMBIA. Value in Health. 2013;16(7).
S. G. Marti,A. Alcaraz,P. Valanzasca,U. G. Ulises,M. McMullen,L. R. Ares,I. Peirano,F. Bessone,H. Fainboim,A. Gadano,O. Galdame,C. Vujacich and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN ARGENTINA. Value in Health. 2013;16(7).
R. Augustovski,A. Palacios,A. Beratarrechea,F. Diez-Canseco,V. Irazola,M. Ramirez-Zea,A. Pichon-Riyiere and A. Rubinstein. COST-EFFECTIVENESS ANALYSIS OF A RANDOMIZED TRIAL OF AN MHEALTH INTERVENTION TO IMPROVE CARDIOMETABOLIC PROFILE IN PREHYPERTENSIVE SUBJECTS FROM LOW-RESOURCE URBAN SETTINGS IN LATIN AMERICA. Value in Health. 2017;20(9).
L. Schluckebier,R. Caetano,O. U. Garay,G. T. Montenegro,M. Custodio,V. Aran and C. Gil Ferreira. Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients. BMC Cancer. 2020;20(1):10.1186/s12885-020-07240-2.
A. Palacios,C. Mengarelli and F. Augustovski. COST ESTIMATION OF THE CHRONIC HEMODIALYSIS AND HEMODIALFILTRATION SERVICES IN ARGENTINA. Value in Health. 2017;20(9):10.1016/j.jval.2017.08.2523.
COST ESTIMATION OF THE CHRONIC HEMODIALYSIS AND HEMODIALFILTRATION SERVICES IN ARGENTINA Ver más »
D. Husereau,M. Drummond,F. Augustovski,E. de Bekker-Grob,A. H. Briggs,C. Carswell,L. Caulley,N. Chaiyakunapruk,D. Greenberg,E. Loder,J. Mauskopf,C. D. Mullins,S. Petrou,R. F. Pwu and S. Staniszewska. Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. Appl Health Econ Health Policy. 2022;20(5):10.1007/s40258-022-00743-y.
D. Husereau,M. Drummond,S. Petrou,C. Carswell,D. Moher,D. Greenberg,F. Augustovski,A. H. Briggs,J. Mauskopf,E. Loder and I. H. E. E. Publica. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value in Health. 2013;16(2):10.1016/j.jval.2013.02.002.
M. Donato,F. C. Carini,M. J. Meschini,I. L. Saubidet,A. Goldberg,M. G. Sarubio,D. Olmos and R. Reina. Consensus for the management of analgesia, sedation and delirium in adults with COVID-19-associated acute respiratory distress syndrome. Rev Bras Ter Intensiva. 2021;33(1):10.5935/0103-507x.20210005.
B. Itkin,S. Straminsky,H. Cáceres,M. Onassis,A. E. García,L. Avanzi,L. Kaminszczik,R. Serna Sejas,M. Rapaccioli,G. Billordo,D. Lavaccara,J. Lanzavecchia,L. Gibbons,E. Settecase and A. Bardach. Comparison of mortality in patients on chemotherapy or immunotherapy during and before the COVID-19 pandemic. Multicenter matched cohort study in Argentina. Revista Peruana de Medicina Experimental y Salud Pública. 2023;40(2):10.17843/rpmesp.2023.402.12519.
A. Dubin,C. I. Loudet,F. J. Hurtado,M. O. Pozo,D. Comande,L. Gibbons,F. R. Cairoli and A. Bardach. Comparison of central venous minus arterial carbon dioxide pressure to arterial minus central venous oxygen content ratio and lactate levels as predictors of mortality in critically ill patients: a systematic review and meta-analysis. Rev Bras Ter Intensiva. 2022;34(2):10.5935/0103-507X.20220026-pt.
